These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38008956)

  • 1. Formulation of aspirin nanoparticles using solvent evaporation method and in vivo evaluation of its antithrombotic effect.
    Alhajj L; Ovenseri Airemwen C; Pozharani LB
    Pak J Pharm Sci; 2023 Sep; 36(5(Special)):1583-1589. PubMed ID: 38008956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.
    Rahman Z; Zidan AS; Habib MJ; Khan MA
    Int J Pharm; 2010 Apr; 389(1-2):186-94. PubMed ID: 20038446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of vanillin by poly(lactic-acid) nanoparticles: Development, characterization and in vitro evaluation of antioxidant activity.
    Dalmolin LF; Khalil NM; Mainardes RM
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():1-8. PubMed ID: 26952391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and in vitro evaluation of polymeric metronidazole nanoparticles.
    Ovenseri AC; Halilu EM
    Pak J Pharm Sci; 2022 Sep; 35(5):1333-1338. PubMed ID: 36451561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Akhter MH; Kumar S; Nomani S
    Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
    [No Abstract]   [Full Text] [Related]  

  • 9. Nifedipine-loaded polymeric nanoparticles: Preparation and in vitro characterization.
    Ozakar E; Cetin M; Ates O; Hacimuftuoglu A
    Pak J Pharm Sci; 2019 Mar; 32(2):547-554. PubMed ID: 31081765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.
    Sahana B; Santra K; Basu S; Mukherjee B
    Int J Nanomedicine; 2010 Sep; 5():621-30. PubMed ID: 20856837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in-vitro, in-vivo characterisation of pioglitazone loaded chitosan/PEG blended PLGA biocompatible nanoparticles.
    Sharma DK; Pattnaik G; Behera A
    J Biomater Sci Polym Ed; 2022 Sep; 33(13):1623-1643. PubMed ID: 35446225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine loaded poly-ɛ-(d,l-lactide-co-caprolactone) nanoparticles as brain delivery system.
    Ammar HO; Ghorab MM; Mahmoud AA; Higazy IM
    Eur J Pharm Sci; 2018 Mar; 115():77-87. PubMed ID: 29341900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis.
    Jogala S; Rachamalla SS; Aukunuru J
    Curr Drug Deliv; 2016; 13(5):698-710. PubMed ID: 26777886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
    Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
    Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulated chitosan-sodium tripolyphosphate nanoparticles for co-encapsulation of ellagic acid and anti-inflammatory peptide: characterization, stability and anti-inflammatory activity.
    Xiong Y; Feng YX; Chang M; Wang Q; Yin SN; Jian LY; Ren DF
    J Sci Food Agric; 2023 May; 103(7):3447-3456. PubMed ID: 36812130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK; Boateng JS
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
    Feng SS; Mu L; Win KY; Huang G
    Curr Med Chem; 2004 Feb; 11(4):413-24. PubMed ID: 14965222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nanoparticulate system for sustained delivery of acid-labile lansoprazole.
    Alai MS; Lin WJ
    Colloids Surf B Biointerfaces; 2013 Nov; 111():453-9. PubMed ID: 23867305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
    Abd-Elhakeem E; El-Nabarawi M; Shamma R
    Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.